Not signed in (Sign In)
Hallo Gast!
Willst du auch dazu beitragen? Wenn du schon einen Account hast, dann log dich jetzt ein oder erstell jetzt einfach einen Account
    • CommentAuthorFreekaze
    • CommentTimeNov 29th 2023
     
    Lenvatinib mesilate, also known as Lenvima, is a small molecule inhibitor of multiple tyrosine kinases (TKIs) that has demonstrated promising efficacy in the treatment of various solid tumors. It is currently approved for the treatment of hepatocellular carcinoma (HCC), renal cell carcinoma (RCC), and non-small cell lung cancer (NSCLC).https://www.qingmupharm.com/products/human-apis/lenvatinib-mesilate-api